Skip to main content

Table 2 Frequency of positive serological tests for CMV infection and CMV PCR among all study participants (n = 201)

From: Screening for maternal cytomegalovirus infection during pregnancy and pregnancy outcome in patients with liver disease: an observational study

  

Normal pregnant women

(n = 128)

Pregnant women with liver diseases not related to pregnancy

(n = 35)

Pregnant women with pregnancy associated liver disease

(n = 38)

P-value

Serological tests for CMV

CMV IgG

Count (%)

53a (41.4%)

27b (77.1%)

24b (63.2%)

< 0.001

Titers (IU/mL)

(mean ± SD)

0.95 ± 0.61a

1.44 ± 0.68b

1.37 ± 0.98b

< 0.001

CMV IgM

Count (%)

8a (6.3%)

11b (31.4%)

6ab (15.8%)

< 0.001

Titers (IU/mL)

(mean ± SD)

0.55 ± 0.38a

0.90 ± 0.56b

0.644 ± 0.45a

0.002

PCR assay for CMV

CMV DNA- based PCR

Count (%)

4a (7.5%)

15b (55.6%)

5a (20.8%)

< 0.001

Titers (IU/mL)

(mean ± SD)

126.40 ± 723.63a

58262.48 ± 182255.34b

136.00 ± 288.23a

< 0.001

  1. Data are shown in n (%) and mean (SD)
  2. Statistically significant values are in bold